The human interferon-alpha species and hybrid proteins
Pestka, S.
Seminars in Oncology 24(3 Suppl 9: S9
1997
ISSN/ISBN: 0093-7754 PMID: 9208870 Document Number: 477761
Ten years of interferon (IFN) therapy have followed the approval of this agent by the US Food and Drug Administration on June 5, 1986. As the first biotherapeutic approved, IFN-alpha paved the way for the many new biotherapeutics. Regardless of this long history, however, we have just touched the surface of understanding the multitude of human IFNs. This report reviews the history of the purification of human leukocyte IFN and key aspects of our current state of knowledge of human leukocyte IFN genes and proteins.
Document emailed within 1 workday
Related Documents
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Samuels, B.L.; Golomb, H.M.; Brownstein, B.H. 1986: In vitro induction of proteins by alpha-interferon in hairy cell leukemia Cancer Research 46(8): 4151-4155
Männel, D.; De Maeyer, E.; Kemler, R.; Cachard, A.; De Maeyer-Guignard, J. 1982: A rat monoclonal antibody against mouse alpha and beta interferon of all molecular weight species Nature 296(5858): 664-665
Mcmullen, G.L.; Sattayasai, N.; Hibbs, A.R.; Marzuki, S. 1990: Antipeptide antibodies against conserved regions of human interferon-alpha: evidence for conformational variations between IFN-alpha subtypes Biochemistry International 21(2): 261-269
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142
Geng, Y.; Choubey, D. 2000: Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha Journal of Biological Regulators and Homeostatic Agents 14(4): 263-268
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Dao, T.; Takeuchi, M.; Fukuda, S.; Kurimoto, M. 1995: Natural human interferon-alpha enhances the expression of intracellular adhesion molecule-1, integrin alpha 2 and beta 1 by a mucosal epithelial cell line Folia Biologica 41(5): 213-225
Han, Z.C.; Briere, J.; Abgrall, J.F.; Le Gall, G.; Parent, D.; Sencebe, L. 1987: Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation Journal of Biological Regulators and Homeostatic Agents 1(4): 195-200
Tanaka, N.; Kojima, K.; Muro, M.; Naomoto, Y.; Moreira, L.F.; Orita, K. 1995: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft Anticancer Research 15(5b): 1949-1952
Brosjö, O.; Bauer, H.C.; Broström, L.A.; Nilsson, O.S.; Reinholt, F.P.; Tribukait, B. 1987: Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation Cancer Research 47(1): 258-262
Mauerhoff, T.; Belfiore, A.; Pujol-Borrell, R.; Bottazzo, G.F. 1994: Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma Tumori 80(4): 301-305
Kase, S.; Kubota, T.; Watanabe, M.; Furukawa, T.; Tanino, H.; Kuo, T.H.; Saikawa, Y.; Teramoto, T.; Kitajima, M. 1995: Recombinant human interferon alpha-2a increases the antitumor activity of 5-fluorouracil on human colon carcinoma xenograft Co-4 without any change in 5-FU pharmacokinetics Anticancer Research 15(1): 153-155
Vanden Broecke, C.; Plasman, P.O.; Pirak, M.; Thiry, E.; Schwers, A.; Piscitelli, S.; Ligongo, G.; Pastoret, P.P.; Werenne, J. 1985: Human recombinant interferon in the bovine species: induction of 2'5'A synthetase and antiviral activity Progress in Clinical and Biological Research 202: 333-338
Utsugi, T.; Sone, S. 1986: Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes Journal of Immunology 136(3): 1117-1122
Maeda, S.; Kawai, T.; Obinata, M.; Fujiwara, H.; Horiuchi, T.; Saeki, Y.; Sato, Y.; Furusawa, M. 1985: Production of human alpha-interferon in silkworm using a baculovirus vector Nature 315(6020): 592-594
Greischel, A.; Tanswell, P.; Busch, U.; Schumacher, K. 1988: Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmoset Arzneimittel-Forschung 38(10): 1539-1543